Skip to content

The Fruhwirth Lab

  • Home
  • Our Research – Imaging Therapies and Cancer
  • Our Team
  • Gallery
  • Contact us…
13th Feb 202013th Feb 2020 Admin

Want to know about the potential of gene editing to engineer cell therapies?

Then please have a look at our latest Open Access Review in Clinical and Translational Medicine: (doi.org/10.1186/s40169-020-0268-z). Congratulations to Candice for a well-received comprehensive and very timely review article!

Share this:

  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on Reddit (Opens in new window) Reddit
  • Tweet
  • Click to print (Opens in new window) Print
Like Loading...
Unknown's avatar

Published by Admin

View all posts by Admin

Post navigation

First time in vivo imaging for Rainbow & Rico
Madeleine awarded a prestigious Winston Churchill Fellowship!

Where we work...

Guy's Cancer Centre,
Innovation Hub 9th floor,
Great Maze Pond,
SE1 9RT London,
United Kingdom
  • SE1 9RT, Great Maze Pond, London, England

RSS Latest Publications

  • Development and characterisation of improved unifocal primary mouse lung cancer models with metastatic potential
  • Stromal lipid species dictate melanoma metastasis and tropism
  • Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis
  • An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities
  • Gene editing enables non-invasive in vivo PET imaging of human induced pluripotent stem cell-derived liver bud organoids
  • Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance
  • In Vitro and Preclinical Systematic Dose-Effect Studies of Auger Electron- and β Particle-Emitting Radionuclides and External Beam Radiation for Cancer Treatment
  • Multi-scale in vivo imaging of tumour development using a germline conditional triple-reporter system
  • Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers
  • Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG12-KL4 peptide to the lungs as potential strategy against non-small cell lung cancer

Translate

Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • The Fruhwirth Lab
    • Already have a WordPress.com account? Log in now.
    • The Fruhwirth Lab
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d